<DOC>
	<DOCNO>NCT01488968</DOCNO>
	<brief_summary>Hypofractionated regimen high-risk prostate cancer allow investigator deliver high biological dos target order improve tumor control acceptable rectal toxicity compare conventional fractionation .</brief_summary>
	<brief_title>Conventional Versus Hypofractionated Radiation High Risk Prostate Patients</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patient 18 year age old Patient histologically proven adenocarcinoma prostate gland needle core sample TURP assign Gleason score . Prostate biopsy perform within 180 day enrollment ( date consent ) . Patient highrisk prostate cancer ( stage T3 T4 ) and/or PSA great equal 20 ng/ml and/or Gleason score 8 10 No clinical radiological evidence nodal distant metastasis ( e ) . In opinion treat oncologist , patient fit undergo radical external beam radiotherapy prostate . Patients accessible treatment follow . Patient history inflammatory bowel disease , anal stenosis , colorectal surgery , repeat endoscopic examinations/interventions related anorectal disease . No history prostatectomy , transurethral resection prostate one occasion previous pelvic radiotherapy . No history androgen suppression great equal 6 month patient willing androgen suppression treatment per standard physician 's discretion . No previous malignancy within last five year except BCC SCC skin highly curable malignancy prognosis cure &gt; 80 % . Patient sign informed consent .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>high risk prostate cancer</keyword>
	<keyword>hypofractionated radiation treatment</keyword>
	<keyword>high biological dos</keyword>
	<keyword>acceptable rectal toxicity</keyword>
	<keyword>Radiation Treatment</keyword>
</DOC>